Glucotrack Study Validates Long-Term Stability of Implantable Glucose Sensor
Event summary
- Glucotrack published a peer-reviewed study in IEEE Sensors Journal on April 7, 2026, demonstrating the long-term stability of its electrochemical glucose sensors.
- The study measured glucose oxidase enzyme decay over one year, the first such measurement reported in literature.
- Sensors used in the study were designed to mimic two-year-old devices, supporting the feasibility of long-life implantable continuous glucose monitors.
- Glucotrack partnered with TTP, a UK-based scientific and engineering organization, for this research.
The big picture
Glucotrack’s study provides critical scientific validation for its long-life implantable glucose sensor, addressing a key technical challenge in diabetes management. The peer-reviewed publication strengthens its position as it moves toward regulatory approvals and commercialization, competing with existing continuous glucose monitoring technologies that typically require frequent calibration or replacement.
What we're watching
- Regulatory Milestones
- The pace at which Glucotrack advances toward FDA IDE submission, leveraging this peer-reviewed data to support its regulatory strategy.
- Technical Validation
- Whether the long-term stability findings translate into clinical success and commercial adoption of the CBGM technology.
- Competitive Positioning
- How Glucotrack’s implantable sensor longevity compares to existing continuous glucose monitoring solutions in the market.